SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?


To: tom pope who wrote (1517)5/14/2003 10:23:13 AM
From: tom pope  Respond to of 3044
 
Briefing wrote:

This news can be viewed as a considerable negative for Celgene (CELG) whose lead drug Thalomid (not approved for MM) will face strong competition from Velcade.


Market is giving a pretty resounding NO! to that judgment. CELG did open lower, but is now solidly green.(Don't own any)